Found: 1
Select item for more details and to access through your institution.
Rationale and design of the "Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled" trial (TOCIBRAS).
- Published in:
- Revista Brasileira de Terapia Intensiva, 2020, v. 32, n. 3, p. 337, doi. 10.5935/0103-507X.20200060
- By:
- Publication type:
- Article